Sign inGet started

DRACHMAN JONATHAN G

Insider CIK 1588467 · SGEN See Remarks · NLTX See Remarks, Director · CALA Director · HARP Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HARP Harpoon Therapeutics, Inc. D To issuer deriv2024-03-112024-03-115,531— $00SEC↗
HARP Harpoon Therapeutics, Inc. D To issuer deriv2024-03-112024-03-112,300— $00SEC↗
HARP Harpoon Therapeutics, Inc. D To issuer deriv2024-03-112024-03-111,016— $00SEC↗
HARP Harpoon Therapeutics, Inc. D To issuer2024-03-112024-03-115,415— $00SEC↗
HARP Harpoon Therapeutics, Inc. A Award2024-03-082024-03-11415— $05,415SEC↗
HARP Harpoon Therapeutics, Inc. A Award2023-11-272023-11-285,000— $05,000SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2023-06-222023-06-2323,000— $023,000SEC↗
NLTX Neoleukin Therapeutics, In A Award deriv2022-08-022022-08-04350,000— $0350,000SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2022-06-222022-06-2410,167— $010,167SEC↗
CALA Calithera Biosciences, Inc P Buy2021-11-102021-11-10200,000$0.86 $172.0K200,000SEC↗
NLTX Neoleukin Therapeutics, In P Buy2021-08-252021-08-2625,000$6.45 $161.3K25,000SEC↗
NLTX Neoleukin Therapeutics, In P Buy2021-08-252021-08-2625,000$6.45 $161.3K25,000SEC↗
NLTX Neoleukin Therapeutics, In P Buy2021-08-242021-08-26100,000$6.11 $611.0K2,348,686SEC↗
NLTX Neoleukin Therapeutics, In A Award deriv2021-08-032021-08-05400,000— $0400,000SEC↗
CALA Calithera Biosciences, Inc A Award deriv2021-06-112021-06-1420,000— $020,000SEC↗
NLTX Neoleukin Therapeutics, In P Buy2021-06-042021-06-0710,000$9.61 $96.1K2,248,686SEC↗
NLTX Neoleukin Therapeutics, In P Buy2021-06-032021-06-0740,000$9.48 $379.2K2,238,686SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2021-05-042021-05-0710,167— $010,167SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2021-05-042021-05-1410,167— $010,167SEC↗
NLTX Neoleukin Therapeutics, In A Award deriv2020-08-102020-08-12420,000— $0420,000SEC↗
CALA Calithera Biosciences, Inc A Award deriv2020-06-092020-06-1120,000— $020,000SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2020-05-282020-06-0110,167— $010,167SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2020-05-282020-06-012,880— $02,880SEC↗
NLTX Neoleukin Therapeutics, In P Buy2019-12-202019-12-20119,047$8.40 $1000.0K2,198,686SEC↗
NLTX Neoleukin Therapeutics, In C Conversion2019-11-122019-12-2012,616— $00SEC↗
NLTX Neoleukin Therapeutics, In C Conversion2019-11-122019-12-201,261,600— $02,079,639SEC↗
NLTX Neoleukin Therapeutics, In P Buy2019-09-112019-09-11136,436$3.30 $450.2K584,428SEC↗
NLTX Neoleukin Therapeutics, In P Buy2019-09-102019-09-1136,742$3.08 $113.2K447,992SEC↗
NLTX Neoleukin Therapeutics, In P Buy2019-09-092019-09-1176,822$2.85 $218.9K411,250SEC↗
NLTX Neoleukin Therapeutics, In A Award deriv2019-08-312019-09-041,650,000— $01,650,000SEC↗
NLTX Neoleukin Therapeutics, In A Award2019-08-082019-08-127,428— $07,428SEC↗
NLTX Neoleukin Therapeutics, In A Award2019-08-082019-08-12334,428— $0334,428SEC↗
NLTX Neoleukin Therapeutics, In A Award2019-08-082019-09-13568,039— $0568,039SEC↗
NLTX Neoleukin Therapeutics, In A Award2019-08-082019-09-1312,616— $012,616SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2019-06-032019-06-0510,167— $010,167SEC↗
CALA Calithera Biosciences, Inc A Award deriv2019-05-302019-06-0311,000— $011,000SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2019-02-072019-03-294,266— $04,266SEC↗
CALA Calithera Biosciences, Inc A Award deriv2018-05-312018-06-0411,000— $011,000SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-03-202018-03-227,000— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-03-202018-03-2213,740— $045,000SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-03-202018-03-226,468— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-03-202018-03-223,831— $00SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2018-03-202018-03-2210,526— $010,526SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-03-202018-03-2213,740$12.00 $164.9K194,973SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-03-202018-03-226,468$15.46 $100.0K181,233SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-03-202018-03-227,000$10.61 $74.3K201,973SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-03-202018-03-223,831$26.10 $100.0K174,765SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-03-052018-03-073,257— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-03-052018-03-077,200— $03,257SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2018-03-052018-03-077,200$52.70 $379.4K170,934SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2018-03-052018-03-073,257$53.12 $173.0K170,934SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-03-052018-03-073,257$8.96 $29.2K174,191SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-03-052018-03-077,200$8.96 $64.5K178,134SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-01-112018-01-166,260— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2018-01-112018-01-1613,156— $07,000SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-01-112018-01-166,260$12.00 $75.1K157,778SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2018-01-112018-01-1613,156$10.61 $139.6K170,934SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2017-10-052017-10-108,223— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2017-10-052017-10-102,344— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2017-10-052017-10-107,249— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2017-10-052017-10-102,344$10.61 $24.9K143,295SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2017-10-052017-10-108,223$12.16 $100.0K151,518SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2017-10-052017-10-107,249$11.09 $80.4K140,951SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2017-08-282017-08-308,502$47.89 $407.2K133,702SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2017-08-242017-08-2510,000— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2017-08-242017-08-2510,000$10.29 $102.9K152,204SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2017-08-242017-08-2510,000$47.54 $475.4K142,204SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2017-08-172017-08-1865,344— $065,344SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2017-08-172017-08-182,156— $02,156SEC↗
SGEN SEATTLE GENETICS INC /WA A Award2017-08-172017-08-1827,000— $0142,204SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2017-07-272017-07-3110,000— $010,000SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2017-07-272017-07-3110,000$54.54 $545.4K115,204SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2017-07-272017-07-3110,000$10.29 $102.9K125,204SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2017-06-222017-06-2610,000— $020,000SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2017-06-222017-06-269,900$64.00 $633.6K115,304SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2017-06-222017-06-2610,000$10.29 $102.9K125,204SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2017-06-222017-06-26100$64.58 $6.5K115,204SEC↗
CALA Calithera Biosciences, Inc A Award deriv2017-06-092017-06-1311,000— $011,000SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2017-01-252017-01-265,000— $00SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2017-01-252017-01-265,000$10.29 $51.4K114,837SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2016-11-092016-11-147,751— $040,000SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2016-11-092016-11-147,751$11.09 $86.0K117,588SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2016-11-092016-11-147,751$66.75 $517.4K109,837SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2016-11-012016-11-033,418$51.74 $176.8K109,837SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2016-09-222016-09-232,249— $030,000SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2016-09-222016-09-232,249$56.75 $127.6K113,255SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2016-09-222016-09-232,249$10.29 $23.1K115,504SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2016-08-272016-08-3070,293— $070,293SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2016-08-272016-08-302,207— $02,207SEC↗
SGEN SEATTLE GENETICS INC /WA A Award2016-08-272016-08-3029,000— $0113,255SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2016-08-222016-08-223,991$46.59 $185.9K84,255SEC↗
CALA Calithera Biosciences, Inc A Award deriv2016-06-142016-06-1611,000— $011,000SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise deriv2016-06-022016-06-065,000— $05,000SEC↗
SGEN SEATTLE GENETICS INC /WA M Exercise2016-06-022016-06-065,000$10.29 $51.4K88,246SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2015-08-252015-08-252,554— $02,554SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2015-08-252015-08-2547,446— $047,446SEC↗
SGEN SEATTLE GENETICS INC /WA A Award2015-08-252015-08-2520,000— $082,724SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2015-08-202015-08-254,462$42.02 $187.5K62,724SEC↗
CALA Calithera Biosciences, Inc A Award deriv2015-06-092015-06-1111,000— $039,355SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2014-08-262014-08-2747,732— $047,732SEC↗
SGEN SEATTLE GENETICS INC /WA A Award deriv2014-08-262014-08-272,268— $02,268SEC↗
SGEN SEATTLE GENETICS INC /WA A Award2014-08-262014-08-2720,000— $066,481SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2014-08-242014-08-272,772$43.55 $120.7K46,481SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2014-02-202014-02-241,241$53.25 $66.1K48,670SEC↗
SGEN SEATTLE GENETICS INC /WA S Sale2014-01-162014-01-211,201$45.75 $54.9K49,911SEC↗
SGEN SEATTLE GENETICS INC /WA A Award2013-10-312013-11-148,100— $051,112SEC↗